SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Meta Platforms, Inc. engages in the development of social media applications. It builds technology that helps people connect and share, find communities, and grow businesses. It operates through the Family of Apps (FoA) and Reality Labs (RL) segments. The FoA segment consists of Facebook, Instagram, Messenger, WhatsApp, and other services. The RL segment includes augmented, mixed and virtual reality related consumer hardware, software, and content. The company was founded by Mark Elliot Zuckerberg, Dustin Moskovitz, Chris R. Hughes, Andrew McCollum, and Eduardo P. Saverin on February 4, 2004, and is headquartered in Menlo Park, CA.

Meta Platforms Inc - Ordinary Shares - Class A

Meta Platforms Inc

Meta Platforms is currently under pressure following media reports that it may be exploring a significant equity raise to support its massive AI infrastructure and data center capital expenditure requirements. Investors are debating whether this potential dilution signifies a long-term strategic commitment to AI dominance or a sign of unsustainable spending, leaving the stock caught between concerns over shareholder impact and its core advertising business performance.

Direxion Shares ETF Trust - Direxion Daily MSCI South Korea Bull 3X ETF

Direxion Daily South Korea Bull 3X Shares

KORU is experiencing extreme volatility and intense community speculation, driven by the massive concentration of high-bandwidth memory giants like Samsung and SK Hynix within its index. Traders are actively debating whether the current price action represents a sustainable super-cycle driven by AI chip demand or a dangerously overextended, leverage-fueled bubble prone to rapid sell-offs.

TON (The Open Network) is a general-purpose&nbsp;blockchain that allows developers to build decentralized apps and tokens.

Toncoin

Toncoin is attracting significant community attention as investors weigh the impact of its deep integration with the Telegram ecosystem against recent market volatility and technical resistance. While some traders are focused on the growth of Ton-based wallet activity and new institutional listings, others are debating the sustainability of current price levels amid ongoing concerns regarding token unlocks and structural market shifts.

NioCorp Developments Ltd. engages in the evaluation, acquisition, exploration, and development of mineral deposits. It focuses on a super alloy materials project in Nebraska for producing niobium, scandium, and titanium. The company was founded on February 27, 1987, and is headquartered in Centennial, CO.

NioCorp Developments Ltd

NioCorp is gaining momentum as investors track the development of the Elk Creek project, which is seen as a key strategic asset for U.S. critical mineral independence amid ongoing supply chain tensions with China. Community discussion is heavily focused on the anticipated feasibility study and upcoming financing catalysts, with many watching for potential government support and institutional accumulation as indicators of a long-term breakout.

Ethereum Classic

Ethereum Classic is trending as frustrated investors debate its long-term viability against other major assets, with many expressing deep disappointment over stagnant price action. The community remains polarized, frequently comparing the token's current performance to its historical highs while split between those liquidating out of exhaustion and others doubling down in anticipation of a potential altcoin rally.

|The Artificial Superintelligence (ASI) Alliance is the world’s largest open-source initiative dedicated to decentralized Artificial General Intelligence (AGI). Formed in April 2024, the ASI Alliance unites SingularityNET, Fetch.ai, and Ocean Protocol, with CUDOS joining as a network member shortly after. The ASI Alliance was established through a community-approved tokenomic merger—combining $AGIX, $FET, and $OCEAN into a single token: $FET. This unified token underpins a collaborative framework designed to scale open-source AI and stand as the largest open-sourced, independent entity in AI research and development. The Alliance is committed to accelerating the advancement of decentralized Artificial General Intelligence (AGI) and, ultimately, Artificial Superintelligence (ASI). It provides a robust, open-source innovation stack, empowering developers, enterprises, and researchers globally to build ethical, scalable, and groundbreaking AI solutions. This ensures that advanced intelligence remains a shared, accessible resource, fostering innovation beyond centralized systems and promoting a future where AI benefits all.

Fetch.ai

Fetch.ai is trending as investors monitor its strength relative to Bitcoin and anticipate its role in the AI agent economy, with community members actively discussing accumulation strategies and bullish long-term potential. Speculation regarding future enterprise adoption and the broader AI narrative continues to drive high engagement, despite ongoing debates about market volatility and supply dynamics.

Avalanche is a high throughput smart contract blockchain&nbsp;platform. Validators secure the network through a proof-of-stake consensus protocol. It is said to be fast, low cost, and environmental friendly.

Avalanche

Avalanche is facing extreme downward pressure, with community members expressing panic and frustration as the token hits multi-year lows. Many investors are debating whether these levels represent a rare buying opportunity or a signal of deeper structural failure, with sentiment largely split between those aggressively averaging down and those who believe the crypto sector is facing a terminal decline.

Axsome Therapeutics, Inc. is a commercial-stage biopharmaceutical company, which engages in the development of novel therapies for the management of central nervous system disorders. Its portfolio consists of Products Overview and Pipeline Overview. The Products Overview includes Auvelity and Sunosi. The Pipeline Overview refers to AXS-05, AXS-07, AXS-12, and AXS-14. The company was founded by Herriot Tabuteau on January 12, 2012 and is headquartered in New York, NY.

Axsome Therapeutics Inc

Axsome Therapeutics is experiencing intense investor interest as the April 30th PDUFA date for the Auvelity label expansion into Alzheimer's agitation approaches, with analysts increasingly confident in an approval. Community sentiment remains bullish, highlighting the drug's potential as a first-in-class treatment for an underserved market and viewing recent stock volatility as a buying opportunity ahead of anticipated regulatory success and upcoming earnings.

Comcast Corp. engages in the provision of video, Internet, and phone services. It operates through the following segments: Residential Connectivity and Platforms, Business Services Connectivity, Media, Studios, and Theme Parks. The Residential Connectivity and Platforms segment consists of residential broadband and wireless services and Sky-branded entertainment television networks and advertising. The Business Service Connectivity segment offers broadband, wireline voice and wireless services through small to medium customers and large enterprises through the HFC network. The Media segment consists of NBCUniversal’s television and streaming platforms, including national, regional, and international cable networks. The Studios segment focuses on NBCUniversal’s film and television studio production and distribution operations. The Theme Parks segment operates Universal theme parks in Orlando, Florida, Hollywood, California, Osaka, Japan, and Beijing, China. The company was founded by Ralph Roberts in 1963 and is headquartered in Philadelphia, PA.

Comcast Corp - Ordinary Shares - Class A

Comcast Corp

Comcast is trending as investors digest the spin-off of its media assets into the newly independent Versant Media Group, with sentiment divided between those seeking bargain entry points at current valuations and skeptics concerned about structural headwinds in the cable sector. The community is actively debating the long-term viability of the legacy cable business versus potential growth from the remaining connectivity, theme parks, and streaming segments.

ProShares Trust - ProShares Bitcoin ETF

ProShares Bitcoin Strategy ETF

The ProShares Bitcoin Strategy ETF is trending as investors grapple with its ongoing price volatility alongside broader market fluctuations in Bitcoin. Community discussion is heavily focused on the contrast between the ETF's consistent monthly dividend payouts and the NAV decay, with many debating whether to hold for income or shift into spot Bitcoin products.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Oramed Pharmaceuticals (NASDAQ:ORMP) Posts Quarterly Earnings Results, Beats Expectations By $0.02 EPS

Oramed Pharmaceuticals (NASDAQ:ORMP - Get Free Report) announced its quarterly earnings data on Thursday. The biotechnology company reported ($0.06) earnings per share (EPS) for the quarter, beating...

Oramed Pharmaceuticals (ORMP) to Release Earnings on Thursday

Oramed Pharmaceuticals (NASDAQ:ORMP) will be releasing earnings before the market opens on Thursday, March 26. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2026-3-26-oramed-pharmaceuticals-inc-stock...

Short Interest in Oramed Pharmaceuticals Inc. (NASDAQ:ORMP) Declines By 16.2%

Oramed Pharmaceuticals Inc. (NASDAQ:ORMP - Get Free Report) saw a significant decrease in short interest during the month of February. As of February 13th, there was short interest totaling 540,151...

Oramed Pharmaceuticals (NASDAQ:ORMP) Stock Price Passes Above 50 Day Moving Average - Here's Why

Oramed Pharmaceuticals (NASDAQ:ORMP) Stock Passes Above 50-Day Moving Average - Here's What Happened...

LFWD Stock Sinks To Record Low On Second Reverse Split In Two Years

Equity

The company announced it would implement a 1-for-12 reverse stock split effective Feb. 24, 2026.

Oramed Pharmaceuticals Inc. (NASDAQ:ORMP) Short Interest Up 57.8% in January

Oramed Pharmaceuticals Inc. (NASDAQ:ORMP - Get Free Report) saw a significant growth in short interest in January. As of January 30th, there was short interest totaling 644,912 shares, a growth of...

Oramed Pharmaceuticals (NASDAQ:ORMP) Shares Pass Above Fifty Day Moving Average - Time to Sell?

Oramed Pharmaceuticals (NASDAQ:ORMP) Stock Price Passes Above 50 Day Moving Average - Should You Sell...

Oramed Pharmaceuticals Inc. (NASDAQ:ORMP) Sees Large Increase in Short Interest

Oramed Pharmaceuticals Inc. (NASDAQ:ORMP - Get Free Report) saw a significant growth in short interest during the month of December. As of December 31st, there was short interest totaling 424,089...

Oramed and Lifeward Announce Strategic Transaction

Oramed and Lifeward Announce Strategic Transaction Oramed and Lifeward Announce Strategic Transaction PR Newswire NEW YORK, Jan. 13, 2026 Transaction Will TransferOramed's Oral Drug Delivery Platform...

Oramed Reports Fiscal Third Quarter 2025 Financial Results

Oramed Reports Fiscal Third Quarter 2025 Financial Results Oramed Reports Fiscal Third Quarter 2025 Financial Results PR Newswire NEW YORK, Nov. 17, 2025 Strong Nine-Month Performance Driven by...

Oramed Pharmaceuticals, Inc. engages in the provision of oral delivery solutions for drugs delivered via injection. It concentrates on the research and development of pharmaceutical solutions, including an oral insulin capsule to be used for the treatment of individuals with diabetes, and the use of orally ingestible capsules or pills for delivery of other polypeptides. The company was founded by Nadav Kidron and Miriam Kidron on April 12, 2002 and is headquartered in New York, NY.

Current Price	$3.71
Prev Close	$3.81
Open	$3.81
Dividend Yield	0.00%
50-Day Moving Average	$3.89
Beta	0.83
Avg. Volume	201,668.87
PE Ratio	1.44

52-Week High	$5.01
52-Week Low	$1.98
Market Capitalization	$155.93M
EPS (Annual)	$1.50
Price to Book	0.64
Revenue Per Employee	$153,846.15

ORMPOramed Pharmaceuticals, Inc

Fundamentals

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest ORMP News